PharmaTher Holdings (XCNQ:PHRM) Change In Payables And Accrued Expense : C$-0.31 Mil (TTM As of Feb. 2024)

View and export this data going back to 2021. Start your Free Trial

What is PharmaTher Holdings Change In Payables And Accrued Expense?

PharmaTher Holdings's Change In Payables And Accrued Expense for the quarter that ended in Feb. 2024 was C$-0.29 Mil. It means PharmaTher Holdings's Accounts Payable & Accrued Expense declined by C$0.29 Mil from Nov. 2023 to Feb. 2024 .

PharmaTher Holdings's Change In Payables And Accrued Expense for the fiscal year that ended in May. 2023 was C$0.56 Mil. It means PharmaTher Holdings's Accounts Payable & Accrued Expense increased by C$0.56 Mil from May. 2022 to May. 2023 .

PharmaTher Holdings Change In Payables And Accrued Expense Historical Data

The historical data trend for PharmaTher Holdings's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaTher Holdings Change In Payables And Accrued Expense Chart

PharmaTher Holdings Annual Data

Trend

May21

May22

May23

Change In Payables And Accrued Expense

0.25

0.16

0.56

PharmaTher Holdings Quarterly Data
	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
Change In Payables And Accrued Expense	Get a 7-Day Free Trial										0.24	0.33	-0.09	-0.26	-0.29

PharmaTher Holdings Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.31 Mil.

PharmaTher Holdings Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of PharmaTher Holdings's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

PharmaTher Holdings (XCNQ:PHRM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PharmaTher Holdings Ltd (XCNQ:PHRM) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

PHRRF:USA

Address

82 Richmond Street East, Toronto, ON, CAN, M5C 1P1

Website

https://www.pharmather.com

PharmaTher Holdings Ltd is a specialty life sciences company focused on the research and development of psychedelic pharmaceuticals for FDA approval to treat mental health, neurological, and pain disorders. Its product pipeline includes Ketamine, KETABET, Microneedle Patch among others.

Executives

Fabio Chianelli

Director, Senior Officer

PharmaTher Holdings (XCNQ:PHRM) Headlines

No Headlines